Literature DB >> 8080012

Renal biopsy findings in presumed hypertensive nephrosclerosis.

B I Freedman1, S S Iskander, V M Buckalew, J M Burkart, R G Appel.   

Abstract

The 'classic' descriptions of renal histologic abnormalities in patients with hypertensive nephrosclerosis were based upon specimens obtained at autopsy or sympathectomy and were evaluated by light microscopy, without the aid of immunofluorescence or electron microscopy. Patients with renal insufficiency accompanied by elevated blood pressure, hypertensive target organ damage (retinal disease and left-ventricular hypertrophy) and mild proteinuria are typically labelled as having hypertensive nephrosclerosis in the absence of renal biopsy material. Herein, we report the clinical summaries and renal pathology from 2 patients initially diagnosed with hypertensive nephrosclerosis. Glomeruli exhibiting focal and segmental sclerosis and interstitial scarring were present in both cases. The presence of primary renal disease in patients felt to have hypertensive nephrosclerosis is likely more common than currently appreciated. This may result from the lack of renal histologic material and the late presentation of these patients to nephrologists. Misclassification of hypertensive nephrosclerosis would impact greatly on the epidemiology of end-stage renal disease and the evaluation and treatment of patients with chronic renal insufficiency.

Entities:  

Mesh:

Year:  1994        PMID: 8080012     DOI: 10.1159/000168695

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  11 in total

1.  Apolipoprotein L1 nephropathy risk variants associate with HDL subfraction concentration in African Americans.

Authors:  Barry I Freedman; Carl D Langefeld; Mariana Murea; Lijun Ma; James D Otvos; Jolyn Turner; Peter A Antinozzi; Jasmin Divers; Pamela J Hicks; Donald W Bowden; Michael V Rocco; John S Parks
Journal:  Nephrol Dial Transplant       Date:  2011-09-19       Impact factor: 5.992

Review 2.  The spectrum of MYH9-associated nephropathy.

Authors:  Meredith A Bostrom; Barry I Freedman
Journal:  Clin J Am Soc Nephrol       Date:  2010-03-18       Impact factor: 8.237

3.  Genetic basis of nondiabetic end-stage renal disease.

Authors:  Barry I Freedman; Rulan S Parekh; W H Linda Kao
Journal:  Semin Nephrol       Date:  2010-03       Impact factor: 5.299

4.  Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans.

Authors:  Barry I Freedman; Pamela J Hicks; Meredith A Bostrom; Mary E Cunningham; Yongmei Liu; Jasmin Divers; Jeffrey B Kopp; Cheryl A Winkler; George W Nelson; Carl D Langefeld; Donald W Bowden
Journal:  Kidney Int       Date:  2009-01-28       Impact factor: 10.612

Review 5.  Hypertension and chronic kidney disease: controversies in pathogenesis and treatment.

Authors:  J L Pirkle; B I Freedman
Journal:  Minerva Urol Nefrol       Date:  2013-03       Impact factor: 3.720

Review 6.  Essential hypertension and risk of nephropathy: a reappraisal.

Authors:  Mariana Murea; Barry I Freedman
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-05       Impact factor: 2.894

Review 7.  Rare genetic causes of complex kidney and urological diseases.

Authors:  Emily E Groopman; Gundula Povysil; David B Goldstein; Ali G Gharavi
Journal:  Nat Rev Nephrol       Date:  2020-08-17       Impact factor: 28.314

8.  Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with albuminuria in hypertensive African Americans: the HyperGEN study.

Authors:  Barry I Freedman; Jeffrey B Kopp; Cheryl A Winkler; George W Nelson; D C Rao; John H Eckfeldt; Mark F Leppert; Pamela J Hicks; Jasmin Divers; Carl D Langefeld; Steven C Hunt
Journal:  Am J Nephrol       Date:  2009-01-20       Impact factor: 3.754

Review 9.  Hypertension-attributed nephropathy: what's in a name?

Authors:  Barry I Freedman; Arthur H Cohen
Journal:  Nat Rev Nephrol       Date:  2015-11-10       Impact factor: 28.314

10.  Retinal Vascular Density as A Novel Biomarker of Acute Renal Injury after Acute Coronary Syndrome.

Authors:  Guillaume Alan; Charles Guenancia; Louis Arnould; Arthur Azemar; Stéphane Pitois; Maud Maza; Florence Bichat; Marianne Zeller; Pierre-Henri Gabrielle; Alain Marie Bron; Catherine Creuzot-Garcher; Yves Cottin
Journal:  Sci Rep       Date:  2019-05-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.